Lapatinib plus paclitaxel versus paclitaxel alone for first line metastatic breast cancer (MBC) in ErbB2+ patients -Quality of Life (QOL) results

Authors :: Anthony C. Segreti
David Cella
M. Arbushites
Y. Wu
M. Walker
Mayur M. Amonkar
M. Koehler
A. DiLeo
Source :: European Journal of Cancer Supplements. 6:171
Publication Year :: 2008
Publisher :: Elsevier BV, 2008.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
business.industry
First line
Lapatinib
medicine.disease
Metastatic breast cancer
chemistry.chemical_compound
Paclitaxel
chemistry
Quality of life
Internal medicine
medicine
business
medicine.drug

Full Text Access

Tools